Industry News

Resmed Announces Agreement to Sell MatrixCare Business
Industry News

Resmed Announces Agreement to Sell MatrixCare Business

Resmed announced it has entered into a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners, a private equity firm focused exclusively on health care. This move reflects Resmed’s 2030 strategy by focusing on high-growth, scalable opportunities in sleep health, breathing health and connected home-based healthcare. The divestiture […]

Monash University and Brigham and Women's Hospital to Advance Innovation in Sleep and Circadian Medicine
Partnerships

Monash University and Brigham and Women’s Hospital to Advance Innovation in Sleep and Circadian Medicine

Monash University and Brigham and Women’s Hospital (BWH) today announce the renewal of their landmark research partnership at a ceremony in Boston, Massachusetts.  Australia’s largest university and one of Boston’s largest hospitals are advancing innovation in sleep and circadian medicine through a world-leading research initiative that will include investigating the […]

sleep 2026
Conferences & Events

SLEEP 2026: What Stood Out From Baltimore

The 40th annual SLEEP meeting drew its usual crowd of clinicians, researchers, technologists, and industry representatives to Baltimore — but this year’s meeting felt different in at least one important way. The pharmaceutical presence on the exhibit floor and in sponsored symposia has grown substantially over the past decade, and […]

prosomnus monitair
Dental Sleep Medicine Partnerships Sleep Apnea

ProSomnus and MonitAir Collaborate to Enhance Connected Care for OSA

ProSomnus Sleep Technologies (“ProSomnus”), pioneer of Smart Sleep Medicine™, and MonitAir, LLC (“MonitAir”), the premier digital health and tele-monitoring platform for sleep medicine announced a collaboration to support connected, longitudinal and personalized care for patients with obstructive sleep apnea (OSA). Through this collaboration, healthcare providers who prescribe a ProSomnus RPMO₂ […]

New SANSA Platform Enhancements & Cardiovascular Risk Data to be Presented at SLEEP 2026
Industry News Technology

Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker

Huxley Medical, a commercial-stage medical technology company expanding access to sleep apnea testing across health systems, cardiology, and primary care, today introduced two additions to its SANSA® platform: SANSA GO™, a point-of-care enrollment model that enables clinics to dispense SANSA at patient visits, and hypoxic burden, an additional measure of […]